CHD3 and CHD9 are the most deleted CHD genes in breast cancer (Figure 4), with 60% and 55% of breast cancer patients showing heterozygous loss, respectively (Chu et al., 2017). This evidence concerns the gene CHD9 and breast carcinoma.